The Study on Atrial Natriuretic Peptide of Cardiomyocytes in a Remote Postperfusion Period in Experiment

The aim of the investigation was to assess the intensity of rat atrial natriuretic peptide (ANP) accumulation and release in a remote post-reperfusion period after a 10-minute circulatory arrest using quantitative analysis of secretory cardiomyocyte granules, morphological and physiological methods.

Materials and Methods. The experiments were carried out on 19 non-linear male rats weighting 220–250 g. Total ischemia (10 min) was simulated by cardiovascular bundle compression according to V.G. Korpachev. The intensity of ANP accumulation and release processes was assessed by quantitative analysis of immunolabeled atrial myocyte granules in transmission electron microscope. We studied tissue rearrangement in myocardium at light-optical level. Physiological condition of animal was assesses in post-reperfusion period by heart rate variability and arterial pressure level.

Results. Rat atrial myocytes in a remote post-reperfusion period were found to have intensified ANP accumulation and release processes. An increased release proceeds against the background of synthetic and proliferative activity of fibroblasts and has a cardioprotective effect promoting the decrease of cardiosclerosis development. Released ANP participates in cardiac rhythm recovery under elevated blood pressure.

Conclusion. Quantitative analysis of immunolabeled granules together with a complex of morphological and physiological methods indicates the intensification of atrial natriuretic peptide accumulation and release in rat atrial cardiomyocytes by the 60th day of post-reperfusion period.

1. de Bold A.J. Thirty years of research on atrial natriuretic factor: historical background and emerging concepts. Can J Pharmacol 2011; 89: 527–531.
2. Martynova M.G., Nakatsaeva E.V., Emel’yanova M.I., Moiseeva O.M., Erokhina I.L. Immunolokalizatsiya predserdnogo natriyureticheskogo peptida v tuchnykh kletkakh perikarda krysy i cheloveka [Immunolocalization of atrial natriuretic peptide in rat and human pericardial mast cells]. Tsitologiya — Cytology 2008; 3: 237–242.
3. Kuhn M. Endothelial actions of atrial and B-type natriuretic peptides. Br J Pharmacol 2012 Jan 5. doi: 10.1111/j.1476-5381.2012.01827.x. [Epub ahead of print].
4. Maksimov V.F., Korostyshevskaya I.M., Markel’ A.L., Filyushina E.E., Yakobson G.S. Natriyureticheskie peptidy serdtsa i arterial’naya gipertenziya: eksperimental’noe issledovanie [Heart natriuretic peptides and arterial hypertension: an experimental study]. Vestnik RAMN — Herald of the Russian Academy of Medical Sciences 2013; 1: 4–9.
5. Mifune H., Honda J., Takamori S., Sugiyama S., Yagami K., Suzuki S. A-type natriuretic peptide level in hypertensive transgenic mice. Exp Anim 2004 Jan; 53(1): 11–9.
6. Rakhcheeva M.V., Bugrova M.L. Izmenenie sootnosheniya granul A- i V- tipov, soderzhashchikh predserdnyy i mozgovoy natriyureticheskie peptidy, v predserdnykh miotsitakh krys v usloviyakh vazorenal’noy gipertenzii [Reproportion of A- and B-type granules containing atrial and brain natriuretic peptides in rat atrial myocytes under renovascular hypertension]. Tsitologiya — Cytology 2010; 8: 629–33.
7. Bugrova M.L., Yakovleva E.I., Abrosimov D.A. Vzaimosvyaz’ intensivnosti sinteza, nakopleniya i sekretsii predserdnogo natriyureticheskogo peptida kardiomiotsitov s urovnem regulyatsii serdechnogo ritma u krys v usloviyakh rannego postreperfuzionnogo perioda [The relationship of synthesis intensity, accumulation and secretion of natriuretic atrial peptide of cardiac myocytes with cardiac rhythm regulation in rats in early post-reperfusion period]. Sovrem Tehnol Med — Modern Technologies in Medicine 2012; 3: 26–30.
8. Korpachev V.G., Lysenkov S.P., Tell’ L.Z. Modelirovanie klinicheskoy smerti i postreanimatsionnoy bolezni u krys [Clinical death and postresuscitation disease simulation in rats]. Patologicheskaya fiziologiya i eksperimental’naya terapiya — Pathological Physiology and Experimental Therapy 1982; 3: 78–80.
9. Mikroskopicheskaya tekhnika [Microscopic equipment]. Pod red. Sarkisova D.S., Perova Yu.L. [Sarkisova D.S., Perova Yu.L. (editor)]. Moscow: Meditsina; 1996; 544 p.
10. Gavrilushkin A.P., Kiselev S.V., Medvedev A.P., Shelepnev A.V., Maslyuk A.P. Geometricheskiy analiz nelineynykh khaoticheskikh kolebaniy v otsenke variabel’nosti ritma serdtsa [Geometry analysis of non-linear chaotic oscillations in heart rate variability assessment]. Nizhny Novgorod; 2001.
11. Korostyshevskaya I.M., Maksimov V.F., Kurganov S.A. Vozmozhnosti ul’trastrukturnoy otsenki sekretornoy aktivnosti predserdnykh kardiomiotsitov [The possibilities of ultrastructural assessment of secretory activity of atrial cardiomyocytes]. Tsitologiya — Cytology 2013; 8: 539–547.
12. Golukhova E.Z., Alieva A.M. Klinicheskoe znachenie opredeleniya natriyureticheskikh peptidov u bol’nykh s khronicheskoy serdechnoy nedostatochnost’yu [Clinical relevance of natriuretic peptide measurement in patients with chronic heart failure]. Kardiologiya i serdechno-sosudistaya khirurgiya — Cardiology and cardiovascular surgery 2007; 1: 45–51.
13. Maki T., Horio T., Yoshihara F., Suga S., Takeo S., Matsuo H., Kangawa K. Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts. British Journal of Pharmacology 2000; 131(6): 1204–1210.
14. Polyakova I.A., Shornikova M.V., Samorukova I.V., Chentsov Yu.S. Ul’trastruktura khondrioma kardiomiotsitov krys pri klinicheskoy smerti i v postreanimatsionnom periode [Ultrastructure of rat cardiomyocyte chondriome in clinical death and postresuscitation period]. Bull Eksp Biol Med — Bulletin of Experimental Biology and Medicine 1999; 1: 95–100.
15. Sokolova R.I., Zhdanov V.S. Gibernatsiya i stanning kak proyavlenie ishemicheskoy disfunktsii miokarda [Hybernation and stanning as an ischemic myocardial dysfunction manifestation]. Arh Patol — Pathology Archives 2002; 1: 50–54.
16. Tsyplenkova V.G. Differentsirovka, «gibernatsiya» i apoptoz kardiomiotsitov — vozmozhnye faktory progressirovaniya diabeticheskoy kardiomiopatii [Differentiation, “hybernation” and apoptosis of cardiomyocytes – possible factors of progressive diabetic cardiomyopathy]. Arh Patol — Pathology Archives 2009; 4: 30–33.
17. Mit’kovskaya N.P., Nizhnikova O.G., Statkevich T.V., Pateyuk I.V., Balysh E.M., Pinchuk A.F. Patogeneticheskie aspekty postinfarktnogo remodelirovaniya miokarda [Pathogenetic aspects of postinfarction myocardium remodeling]. Meditsinskiy zhurnal — Medical journal 2013; 1: 12–18.
18. Gurevich M.A., Mravyan S.R., Veselova T.E. Znachenie sistemy predserdnykh natriyureticheskikh peptidov pri serdechnoy nedostatochnosti i arterial’noy gipertenzii. [The significance of atrial natriuretic peptide system in heart failure and arterial hypertension]. Kardiologiia — Cardiology 2003; 9: 81–85.
19. Bugrimova M.A., Savina N.M., Vanieva O.S., Sidorenko B.A. Mozgovoy natriyureticheskiy peptid kak marker i faktor prognoza pri khronicheskoy serdechnoy nedostatochnosti [Brain natriuretic peptide as a marker and prognosis factor in chronic heart failure]. Kardiologiia — Cardiology 2006; 1: 51–57.
20. Fujii Y., Ishino K., Tomii T., Kanamitsu H., Fujita Y., Mitsui H., Sano S. Atrionatriuretic peptide improves left ventricular function after myocardial global ischemia-reperfusion in hypoxic hearts. Artif Organs 2011 Nov 1. doi: 10.1111/j.1525-1594.2011.01358.x. [Epub ahead of print].
21. Perrin M.J., Gollob M.H. The role of atrial natriuretic peptide in modulating cardiac electrophysiology. Heart rhythm 2012; 4: 610–615.

Bugrova M.L., Abrosimov D.А., Yakovleva E.I., Baskina О.S., Ermolin I.L. The Study on Atrial Natriuretic Peptide of Cardiomyocytes in a Remote Postperfusion Period in Experiment. Sovremennye tehnologii v medicine 2013; 5(4): 39